The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Floxapen 500mg Capsules



Actavis Group PTC ehfPA1380/011/002

Main Information

Trade NameFloxapen 500mg Capsules
Active SubstancesFLUCLOXACILLIN SODIUM
Dosage FormCapsule, hard
Licence HolderActavis Group PTC ehf
Licence NumberPA1380/011/002

Group Information

ATC CodeJ01CF Beta-lactamase resistant penicillins
J01CF05 flucloxacillin

Status

License statusWithdrawn
Withdrawn Date28/05/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListFlucloxacillin 500mg Capsules
Interchangeable List CodeIC0089-117-001
Interchangeable List DocumentPDF of Interchangeable List
« Back